C0206116||microglial
C0012151||biodiesel exhaust
C0020538||hypertensive
C0034721||rats
C0442529||urban
C0007682||central nervous system (CNS) diseases
C1535926||neurodevelopmental disorders
C0206116||Microglia
C0312740||immune cells
C0950580||sentinels
C0006104||brain
C0449426||source
C0007682||CNS effects
C2717891||soy-based biofuel
C0027361||public
C0543488||interest
C2717891||soy biofuel
C0006104||brain
C0027361||people
C0521987||preexisting disease conditions
C0034705||spontaneously hypertensive rats
C0034705||spontaneously hypertensive rats
C2712122||normotensive
C0034709||Wistar Kyoto (WKY) rats
C0012151||100% Soy-based Biodiesel Exhaust
C0012151||100SBDE
C0004048||inhalation
C1455000||Ionized calcium-binding adapter molecule-1
C1455000||Ionized calcium-binding adapter molecule-1
C0487602||staining
C0206116||microglia
C0038590||substantia nigra
C0012151||100SBDE
C0034721||rats
C0034705||spontaneously hypertensive rats
C4234382||Aconitase activity
C0016733||frontal cortex
C0007765||cerebellum
C0034709||WKY rats
C0012151||100SBDE
C0079189||cytokine
C1171362||expression
C0033684||nitrated protein
C0003763||arginase1
C1171362||expression
C1273723||brain regions
C0034721||rat strain
C0012151||100SBDE
C1455000||Ionized calcium-binding adapter molecule-1
C1515670||mRNA expression
C1870161||CX3CR1
C1515670||mRNA expression
C0010097||striatum
C0012151||100SBDE
C0034721||exposed rats
C0013081||downregulation
C0663627||fractalkine receptor
C0206116||microglia
C1273723||brain region
C0206116||microglia
C0442726||detecting
C0012151||100SBDE
C1171362||expression
C1870161||CX3CR1
C0005516||inflammatory markers
C0024432||M1
C4086555||M2
C0006104||brain